Eli Lilly sues HHS to halt any 340B-related monetary penalties
The Biden administration’s fight with drugmakers over a drug discount program, known as 340B, is starting to boil over.
Just days after HHS set a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
